- Home
- ECOR vs OSTX Comparison
ECOR vs OSTX Comparison
Compare ECOR & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- OSTX
- Stock Information
- Founded
- ECOR 2005
- OSTX 2018
- Country
- ECOR United States
- OSTX United States
- Employees
- ECOR N/A
- OSTX N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OSTX
- Sector
- ECOR Health Care
- OSTX
- Exchange
- ECOR Nasdaq
- OSTX NYSE
- Market Cap
- ECOR 87.1M
- OSTX 86.5M
- IPO Year
- ECOR 2018
- OSTX 2024
- Fundamental
- Price
- ECOR $10.94
- OSTX $2.25
- Analyst Decision
- ECOR Strong Buy
- OSTX Strong Buy
- Analyst Count
- ECOR 1
- OSTX 1
- Target Price
- ECOR $15.00
- OSTX $21.00
- AVG Volume (30 Days)
- ECOR 157.1K
- OSTX 19.7K
- Earning Date
- ECOR 11-13-2024
- OSTX 11-26-2024
- Dividend Yield
- ECOR N/A
- OSTX N/A
- EPS Growth
- ECOR N/A
- OSTX N/A
- EPS
- ECOR N/A
- OSTX N/A
- Revenue
- ECOR $23,327,000.00
- OSTX N/A
- Revenue This Year
- ECOR $62.51
- OSTX N/A
- Revenue Next Year
- ECOR $31.32
- OSTX $9,900.00
- P/E Ratio
- ECOR N/A
- OSTX N/A
- Revenue Growth
- ECOR 74.10
- OSTX N/A
- 52 Week Low
- ECOR $5.02
- OSTX $2.10
- 52 Week High
- ECOR $14.20
- OSTX $4.90
- Technical
- Relative Strength Index (RSI)
- ECOR 49.51
- OSTX N/A
- Support Level
- ECOR $10.40
- OSTX N/A
- Resistance Level
- ECOR $14.20
- OSTX N/A
- Average True Range (ATR)
- ECOR 1.25
- OSTX 0.00
- MACD
- ECOR -0.14
- OSTX 0.00
- Stochastic Oscillator
- ECOR 14.21
- OSTX 0.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.